Andrew Powell

Andrew Kenneth William Powell is currently the Director at Cure Network Ventures, Inc., the Director at SciaDerm, Inc., and the Associate at Gibson, Dunn & Crutcher LLP.
He previously served as the Independent Director at Lifecore Biomedical, Inc., Synthorx, Inc., Motif Bio Plc, Silverback Therapeutics, Inc., and Aclaris Therapeutics, Inc. He also held positions as the Vice President & Chief International Counsel at Baxter International, Inc., the Senior Vice President & General Counsel at ImClone LLC, the Secretary, Executive VP & General Counsel at CollaGenex Pharmaceuticals, Inc., InterMune, Inc., Medivation LLC (California), and Cornerstone Therapeutics, Inc. Mr. Powell received his undergraduate degree from The University of North Carolina at Chapel Hill in 1979 and his graduate degree from Stanford Law School in 1985.